Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Syndecan-1 ELISA Kit (AC3030)
Cat.#: ASET-1619
Specifications
Description Human Syndecan-1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Syndecan-1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.05 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1389 Human Thyroid Hormone Receptor beta ELISA Kit (AC2800) Quantitative inquiry ASET-1065 Mouse Visfatin ELISA Kit (AC2476) Quantitative inquiry ASET-1040 Human AMBRA1 ELISA Kit (AC2451) Quantitative inquiry ASET-2370 Mouse Nell1 ELISA Kit (AC3781) Quantitative inquiry ASET-1672 Human TMPRSS4 ELISA Kit (AC3083) Quantitative inquiry ASET-2088 Canine Adenosine A1 Receptor ELISA Kit (AC3499) Quantitative inquiry ASET-1045 Human CYP1B1 ELISA Kit (AC2456) Quantitative inquiry ASET-1298 Guinea Pig Insulin ELISA Kit (AC2709) Quantitative inquiry ASET-2267 Human Apelin ELISA Kit (AC3678) Quantitative inquiry ASET-1949 Human KCNJ14 ELISA Kit (AC3360) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket